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Two  recent  studies  (1,  2)  have  identified  cells  in  human  blood  that  fully 
resemble  the dendritic cells described  previously in  mice and rats (3).  Among 
other similarities, the human equivalent is Ia positive and Fc receptor negative, 
occurs in trace numbers (<1% of blood mononuclear cells), and acts as a potent 
stimulator of T  cell proliferation in vitro. For example, preparations enriched in 
dendritic cells are  10-100  times more active than monocytes or lymphocytes in 
stimulating the syngeneic and allogeneic mixed  leukocyte reactions (MLR) ~ as 
well as oxidative mitogenesis--the proliferation of periodate-modified T  cells (1, 
2). Therefore the prevailing concept that monocytes are the principal accessory 
cells in man must be reexamined. 
Monoclonal antibodies that distinguish macrophages from dendritic cells pro- 
vide  new  probes  for  accessory  or  stimulator  cells  in  the  immune  response. 
Selective depletion of murine dendritic cells, with specific antibody and comple- 
ment, decreases accessory function dramatically (4-6).  In man, antidendritic cell 
antibodies  are  not  available,  but  alternative  and  useful  reagents  have  been 
obtained.  For example,  3C10  and  1 D9 are related antimacrophage antibodies 
that do not react with dendritic cells, while 9.3F10 is an anti-HLA class II reagent 
(7) that reacts with both cell types.  In this paper,  we use these monoclonals to 
study the requirements for T  cell proliferation. T  cell growth is severely reduced 
when accessory cells are depleted with 9.3F10 and complement, or when an Fab 
fragment of 9.3F10  is  added  to  the  culture.  Positive and  negative  monocyte 
selection experiments, with the fluorescence-activated cell sorter and with com- 
plement-mediated cytolysis, indicate that monocytes contribute little if at all to 
accessory function. In contrast, highly enriched and monocyte-depleted dendritic 
cells are potent stimulators of the syngeneic and allogeneic MLR and the response 
to soluble tetanus toxoid. Monocytes and dendritic cells express similar levels of 
Ia antigens, however, indicating that class II products need to be expressed on 
dendritic cells to induce several T  cell-proliferative responses in man. 
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Materials and  Methods 
Monoclonal Antibodies.  The antibodies used in this study were described previously (7). 
3C10 (IgG~b) and  1D9  (IgG1) are antimonocyte (7);  BA-1  (IgM) and  Leu-1  (IgG~,) are 
anti-B and -T lymphocyte antibodies, purchased from Hybritech, Inc., La Jolla, CA and 
Becton, Dickinson & Co., Oxnard,  CA, respectively; 9.3F10  (IgG2a) reacts with class  II 
major histocompatibility products or Ia-like antigens (7).  Purified Ig preparations were 
used throughout. 
Cytotoxicity Assays.  A one-stage cytotoxicity protocol was used in which equal volumes 
of cells,  antibody, and rabbit complement (C') were incubated for 60 rain at 37°C.  All 
reagents  were  diluted  in  RPMI  1640  (Gibco  Laboratories,  Grand  Island,  NY),  0.3% 
bovine serum albumin, 25 mM Hepes buffer, and  10 #g/ml deoxyribonuclease (type I; 
Sigma Chemical Co., St. Louis, MO). The final concentrations of reagents were  1.6-2.5 
X  106/ml for cells,  1-10 t~g/ml for antibodies, and  1:9 for rabbit serum reconstituted 
from  lyophilized  samples from  two different  rabbits.  After  treatment,  the  cells  were 
washed three times and used as accessory cells or as responders in T  cell proliferation 
assays. All cell numbers in Results are viable (trypan blue excluding) counts. Elimination 
of monocytes was monitored by cytology and nonspecific esterase staining (1). 
Cell  Sorting.  Adherent  blood  mononuclear  cells  were  cultured  overnight  and  the 
released fraction (50% or more monocytes) was sorted into monocyte-rich and depleted 
components using fluoresceinated  1D9 antimonocyte antibody and a  fluorescence-acti- 
vated cell sorter (FACS II; B-D FACS Systems, Sunnyvale, CA), equipped with a Spectra- 
Physics 5 W argon-ion laser. Optical filtration was done by placing 520- and 530-nm "cut- 
on" filters (Ditric Optics, Hudson,  MA) in series. The following instrument parameters 
were  used  in  all  cell  sorting and analytical experiments:  fluorescence-excitation wave- 
length,  488.8;  laser  power,  300  roW;  photomultiplier  voltage,  750  V;  fluorescence 
preamplifier setting,  1-8;  light scatter preamplifier setting,  2.  Data were collected and 
displayed as dual parameter contour diagrams of fluorescence and light scattering inten- 
sity.  Generally,  the  cells were sorted at  ~2,200  cells per minute.  The abort rate  was 
<15% and total cell recovery was 80%.  Directly fluoresceinated  1  D9 was used to stain 
cells because, relative to indirect immunofluorescence, there were fewer dead cells (3 vs. 
~> 10%) and staining was simpler and faster.  1  D9 antibody was conjugated to fluorescein 
isothiocyanate isomer  1 (FITC-celite, F-1628;  Sigma Chemical Co.).  0.5  mg of 1D9  Ig 
and 0.5  mg of FITC-celite were mixed for 1 h at room temperature in 0.33  ml sodium 
carbonate, 0.1  M, pH 9.5.  Unconjugated FITC was removed by gel filtration on a 7.5 × 
600-mm  LKB  TSK-3000  column  (LKB-Produkter  AB,  Bromma,  Sweden)  in  0.1  M 
Na2PO4, pH 6.5, with 0.02% NAN3. The resulting reagent had a fluorescein/protein ratio 
of 4.8 and was used to stain cells at 5 #g for 5 ×  106 cells/ml RPMI 1640 with 10% horse 
serum, on ice for 45 min. The cells were washed twice in phosphate-buffered saline before 
sorting under sterile conditions. 
Cells.  Blood samples were obtained from normal volunteers in our laboratory, or were 
purchased as buffy coats from the Greater N. Y. Blood Center. Whole or unfractionated 
mononuclear cells  were  prepared  from  FicolI-Hypaque columns.  Adherent  cells  were 
selected after culture on  100-mm plastic petri dishes (Falcon Labware, Oxnard,  CA) in 
RPMI  1640  supplemented  with  5%  fetal  calf serum.  The  adherent  cells  represented 
20-40%  of total cells and typically were comprised of 50-70%  monocytes, 20-40%  B 
cells,  10-20% T  cells, and  1-4% dendritic cells.  After overnight culture, 60-80% of the 
adherent cells had detached, and these were either used as accessory cells directly or to 
prepare dendritic  cells.  Monocytes that  remained attached  to the  dish  after overnight 
culture were shown previously to be weak or inactive as accessory cells (1). Dendritic cells 
were  enriched  by a  new  technique  described  in  the  accompanying paper (7).  Briefly, 
adherent cells were cultured overnight, treated with 3C10 and C' for 1 h, washed, and 
treated again with  3C10 along with BA-I and Leu-1  (anti-B and anti-T cell) antibodies 
and C'. After 2 h  of additional culture, viable cells were retrieved by flotation on dense 
albumin  columns.  0.1-0.2%  of  the  starting  mononuclear  cells  were  recovered,  and 
70-80%  were  dendritic  cells  by cytologic criteria;  contamination  with  monocytes and 
lymphocytes was <2%. Control low density populations were adherent cells that had been 176  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
exposed to C'  in the absence of antibody; these contained 60% monocytes and 5-10% 
dendritic cells.  Monocyte-enriched fractions were also  obtained from firmly adherent 
populations (see above and reference 1) detached with EDTA. 
T Cell Proliferation Assays.  Graded doses of viable, irradiated (3,000 rad) stimulator 
cells were added to 1.5 ×  105 (6-mm flat microtest wells, 3596; Costar, Cambridge, MA.) 
or 2 ×  106 (16-ram flat macrotest wells,  3524; Costar) responding T  ceils, obtained by 
passing nonadherent blood mononuclear cells over nylon wool as described (1).  These 
responder cells were unrelated to the donor (allogeneic MLR), syngeneic to the donor 
(syngeneic MLR), or syngeneic and  modified with  2  mM  sodium periodate (oxidative 
mitogenesis). Cultures were maintained in RPMI  1640 supplemented with  10% human 
AB serum, 20 t~g/ml gentamycin, 100 U/ml penicillin, 5 x  10  -5 M 2-mercaptoethanol, 
and 1 mM glutamine. Proliferation was measured with a  1 ~Ci pulse of [3H]thymidine (6 
Ci/mM; Schwarz/Mann Division,  Becton, Dickinson & Co., Orangeburg, NY) at 96-114 
h (MLR) or 48-64 h (oxidative mitogenesis). 
Proliferative responses to soluble antigens were performed in cultures of 0.3 and  1.0 
x  105 responders in round-bottomed wells (Linbro Chemical Co.,  Hamden, CT).  15% 
autologous plasma, rather than 10% AB serum was used, because it supported higher and 
more consistent proliferative responses. The antigens were tetanus toxoid (Massachusetts 
Dep't of Health,  Boston, MA.) and Candida albicans extract (Hollister-Stier, Spokane, 
WA.). Cultures were pulsed with  1 ~Ci of [~H]thymidine at 120-140 h. Responder cells 
were either unfractionated mononuclear cells  or purified T  cells  prepared by passing 
nonadherent  populations  over nylon  wool  columns  followed by  further depletion  of 
accessory cells with 9.3F10 (anti-Ia) antibody and complement. 
Blocking and Binding Studies with Anti-Ia or Anti-Class II Antibodies.  9.3F10 is considered 
to be an anti-class  II reagent because it precipitates typical 33,000 and 29,000 tool wt 
class II polypeptides from monocytes, and reacts with B cells, monocytes, dendritic cells, 
and B cell lines, but not T  cells or HLA-DR-negative lines such as K562, CEM T, U937, 
H L60, and Jurkat (7). The precise specificities identified by 9.3 F 10 have not been defined. 
An Fab fragment was prepared by papain digestion of ascites-derived Ig as described (7). 
The Fab fragment was stored as a sterile solution of 500 ug/ml and used at a concentration 
of 6 ~g/ml to block T  cell proliferative responses in vitro. Control noninhibitory Fab 
fragments were 3C10 (antimonocyte) and 3G8 (antid-Fc7 receptor, kindly provided by 
Dr. Howard Fleit and colleagues, [8]). On a molar basis,  9.3F10 Fab was  10 times less 
effective than 9.3F 10 Ig in blocking proliferative responses to tetanus toxoid. Quantitative 
25  5  binding studies with  I-9.3F10 Fab were performed on 0.5-1  x  10  purified dendritic 
cells and monocytes, as described (7). 
Results 
Monoclonal antimonocyte antibodies were used  in  three sets of experiments 
to  identify  the  active  stimulator  for  T  cell  growth  in  man.  Specifically,  the 
antibodies were used to deplete monocytes by C'-mediated cytotoxicity, to sort 
monocytes from other cell types on the FACS, and to help purify dendritic cells. 
Since  Ia  + monocytes proved  to be weak accessory cells,  we  tested whether all 
proliferative responses were mediated by HLA class  II determinants and com- 
pared  the  expression  of class  II  antigens  on  monocytes and  dendritic  cells in 
quantitative binding studies. 
Selective  Monocyte  Depletion  with  Antibody  and  C'  Does  Not  Reduce  Stimulator), 
Capacih, for  the MLR  and  Oxidative  Mitogenesis.  3C10  is  an  IgG2b  monoclonal 
antibody that in the presence of rabbit C'  kills >95% of human monocytes but 
no other blood cells including dendritic cells (7).  In  the experiments described 
here,  monocyte depletion  was  monitored  by nonspecific esterase  staining  (see 
Fig.  1 and legends to Tables I-III). Monocyte-depleted mononuclear cells were 
fully capable of stimulating the allogeneic MLR and oxidative mitogenesis, even VAN  VOORHIS ET  AL.  177 
FIGURE  1.  Elimination  of monocytes with 3C I0 and C'. Cells were exposed to C' only (le~) 
or 3C 10 antibody and C' (right),  after which  cytospin  preparations were stained for nonspecific 
esterase. The top frames are unfractionated mononuclear cells and the lower frames adherent 
populations. Ceils with dark cytoplasmic staining were classified as monocytes. Monocyte- 
depleted populations contain lymphoid  cells with  single, esterase-positive  granules, x 400. 
at limiting stimulator to responder ratios (Table I).  In contrast, treatment with 
the  anti-class  II  monoclonal  antibody  9.3F10  (7)  and  C'  totally  eliminated 
stimulating capacity  (Table  I).  In  most  instances  (e.g.,  experiments  2  and  3, 
Table I), treatment with anti-Ia alone was partially inhibitory. 
The  monocyte depletion  experiments  were  repeated  using adherent  mono- 
nuclear cells as stimulators.  These  cells  were enriched in stimulating capacity, 
relative to total mononuclear cells (compare the proliferative responses in Tables 
I and II). Removal of monocytes (Fig.  1) did not reduce accessory function and, 
in some cases, stimulatory function was actually increased (experiments 1 and 2, 
Table II). The latter can be attributed to the increased percentage of dendritic 
cells in the monocyte-depleted adherent fractions. In all cases, significant MLR 
and oxidative mitogenesis were induced even at limiting stimulator to responder 
ratios (1:12). At this dose, cultures stimulated with monocyte-depleted adherent 
cells had <1  monocyte per 2,000 T  cells. 
Antigen-induced Proliferative  Responses in Monocyte-depleted Cultures.  It is known 
that large numbers of monocyte-enriched adherent cells ('~5%  of the culture) 
are  required  to reconstitute  normal antigen-induced proliferative  response  by 
purified T  lymphocytes (9-13).  The number of monocytes surviving treatment 
with 3C10 antibody and C'  was so low (<1%  of the culture) that we could ask 
whether selective monocyte depletion had any effect on proliferative responses 
to soluble protein  antigens.  Responses to  tetanus toxoid and Candida albicans 178  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
TABLE  I 
Accessory Function of Monocyte-depleted  Blood Mononuclear Cells." Stimulation of the 1 ° MLR 
and Oxidative Mitogenesis 
Treatment of 
mononuclear cells 
Proliferative response (cpm [SH]thymidine) to graded doses of 
stimulators 
Antibody  Comple-  Oxidative mitogenesis  1 ° MLR 
ment 
Experiment 1  33%  16%  8%  33%  16%  8% 
None  None  25,652  19,006  13,253  24,315  17,807  8,838 
None  Active  25,811  18,604  13,828  43,292  26,914  12,443 
Antimonocyte  Heated  24,255  15,371  11,525  42,217  19,604  10,666 
Antimonocyte  Active  34,551  22,173  11,101  45,862  22,392  9,406 
No stimulators  2,736  5,771 
Experiment 2  33%  16%  8% 
None  None  34,251  16,675  8,395 
None  Heated  17,693  9,134  5,412 
None  Active  17,560  13,348  4,281 
Antimonocyte  Heated  Not tested  20,586  18,262  6,839 
Antimonocyte  Active  24,117  10,344  3,125 
Anti-la  Heated  6,447  3,915  2,858 
Anti-la  Active  1,340  384  275 
No stimulators  77 
Experiment 3  50%  25%  13% 
None  None  30,928  24,404  15,804 
None  Heated  17,554  14,415  11,441 
None  Active  10,137  10,369  8,351 
Antimonocyte  Heated  11,971  12,694  13,536 
Antimonocyte  Active  28,570  14,309  6,017 
Anti-la  Heated  8,263  7,930  9,025 
Anti-Ia  Active  1,610  2,418  4,013 
No stimulators  673 
Not tested 
Experiment 4  33%  16%  8% 
None  None  32,534  13,396  9,764 
None  Active  11,375  4,175  4,089  Not tested 
Antimonocyte  Heated  44,630  18,740  12,089 
Antimonocyte  Active  34,413  16,610  6,833 
No stimulators  158 
1.5  x  105  autologous  periodate-treated  (oxidative  mitogenesis)  or  allogeneic  (1 °  MLR),  nylon- 
nonadherent  T  cells were  cultured  in  triplicate  microtest  wells with  graded  doses  of irradiated 
mononuclear cells that had been treated with antibody and C' as shown. Rabbit C' was either freshly 
reconstituted (active) or heat-inactivated at 56°C for 30 min (heated). The cells were pulsed with 1 
ttCi/well [SH]thymidine at 54-72  h  for oxidative mitogenesis or  128-144 h  for the  1 ° MLR. The 
data is expressed as the mean cpm. Standard deviations were <15%. The percentage of monocytes 
in the stimulator populations, by diffuse nonspecific esterase staining, was: 
Experiment  No  Antimonocyte  Active C'  Antimonocyte 
treatment  +  heated C'  only  + active C'  Anti-la + active C' 
1  43  42  41  2  Not done 
2  43  45  43  1  33 
3  32  Not done  28  0.5  6 
4  30  33  32  I  Not done VAN  VOORHIS  ET  AL. 
TABLE  II 
Accessory Function of Monocyte-depleted Adherent Blood Cells 
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Treatment of adherent cells 
Antibody  Comple- 
ment 
Proliferative response (cpm [3H]thymidine)  to graded doses of 
stimulators 
33%  16%  8%  33%  16%  8% 
Oxidative mitogenesis  1 ° MLR 
Experiment 1 
None  None  70,900  46,014  35,548 
None  Active  44,198  38,074  21,337 
Antimonocyte  Heated  68,677  56,199  38,171 
Antimonocyte  Active  136,857  95,795  73,876 
No stimulators  847 
Experiment 2 
None  None 
None  Active 
Antimonocyte  Heated 
Antimonocyte  Active 
No stimulators 
Not tested 
41,679  25,379  20,149  52,983  35,866  27,033 
28,305  21,744  17,726  71,700  36,617  20,074 
59,079  55,640  36,476  126,355  84,172  42,425 
84,663  89,190  61,279  144,122  139,980  81,070 
2,091  1,581 
Experiment 3 
None  None  35,689  25,567  16,797 
None  Active  47,071  31,329  24,002 
Antimonocyte  None  40,369  30,864  19,835 
Antimonocyte  Active  57,626  33,039  20,187 
No stimulators  1,421 
Not tested 
Experiment 4 
None  None  29,951  19,955  10,685  7,802 
None  Heated  32,934  21,514  14,365  5,563 
None  Active  26,578  15,195  11,560  6,649 
Antimonocyte  Heated  21,737  15,178  10,725  7,523 
Antimonocyte  Active  30,425  11,622 
Anti-la  Heated  1,717  1,737  2,070  1,006 
Anti-la  Active  906  829  993  927 
No stimulators  1,109  373 
The experiments were constructed as in Table l  except that irradiated adherent mononuclear cells 
were used as accessory cells or stimulators. The percentage of monocytes by nonspecific esterase 
staining was: 
Experiment  No C'  C' only  Antimonocyte + 
C' 
1  40  --  0.2 
2  60  --  0.5 
3  53  50  4 
4  53  51  1 
remained  intact  in  the  virtual absence of monocytes  even  under  culture condi- 
tions that  were  limiting in  terms of antigen dose,  cell dose, and  time in culture 
(Table III). Treatment  with 9.3F 10 antibody (anti-class II or anti-Ia-like) and C' 
dramatically reduced  proliferative responses. Therefore  monocytes seem unnec- 
essary for proliferative responses to soluble antigens; treatment  with anti-class II 
antibodies and C' probably eliminates responses by killing another  cell type such 
as the Ia  + dendritic cell. 
Sorting of Monocvtes Using Fluoresceinated Monoclonal Antibody.  Directly fluores- 180  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
TABLE  III 
Monocyte Depletion Does Not Alter Responses to Soluble Antigens 
Treatment of blood 
mononuclear cells 
Proliferative response (cpm [SH]thymidine) 
1 x  l0 s cells  3 x  104 cells 
Antibody  Comple-  No  Candida  Tetanus  No 
ment  antigen  toxoid  antigen  Candida 
Tetanus 
toxoid 
Experiment 1 
None  None  7,554  19,903  59,743 
None  Heated  7,803  18,935  48,078 
None  Active  8,963  17,030  54,236 
Antimonocyte  Heated  6,543  9,353  47,567 
Antimonocyte  Active  12,234  19,581  56,637 
Anti-Ia  Heated  11,178  24,732  46,219 
Anti-Ia  Active  139  325  4,906 
Not tested 
Experiment 2 
None  Heated  5,205  15,052  10,649  983  1,541  3,733 
None  Active  4,443  15,183  11,203  338  1,627  3,112 
Antimonocyte  Heated  3,976  8,018  10,448  734  2,281  2,237 
Antimonocyte  Active  3,493  13,592  15,809  238  1,567  3,130 
Anti-la  Heated  879  4,410  7,115  538  1,545  1,929 
Anti-Ia  Active  218  668  1,434  161  360  707 
Experiment 3 
None  None  1,552  6,053  15,868  1,143  1,223  3,745 
None  Heated  3,883  4,354  17,138  567  1,208  5,279 
None  Active  2,772  5,455  17,115  445  1,602  4,638 
Antimonocyte  Heated  2,334  4,765  17,674  751  762  5,174 
Antimonocyte  Active  1,832  4,485  19,679  524  461  5,177 
Anti-la  Heated  921  2,376  14,738  702  573  3,786 
Anti-la  Active  545  191  2,378  675  696  654 
Mononuclear cells were obtained from Ficoll-Hypaque columns and treated with antibody and C' as 
indicated. The cells were washed and cultured in  15%  vol/vol isologous plasma at  1 x  l0 s or 3 x 
104 cells per round-bottomed microtest well. Cultures were exposed on day 5-6 for  16-20 h  with 
[3H]thymidine  at  0.5  u.Ci/well.  Experiments  1  and  3  were  from  the  same  donor.  Additional 
components to the experiments which are not shown include: (a) In experiment 2, a nine-fold lower 
dose of antigen was used. The responses were 50% of those shown, but the effects of antibody and 
C' were unchanged qualitatively. (b) In experiment 2, a replicate experiment was cultured for 5 d. 
Proliferative responses were  ~75%  of those shown, but qualitatively the responses of the various 
treatment  groups  were  unchanged.  (c)  In  experiment  3,  a  replicate experiment  was  cultured  in 
pooled AB serum, rather than isologous plasma. The use of AB serum reduced both background (no 
antigen; <1,000 cpm/culture) and antigen-stimulated responses. Qualitatively the various treatment 
groups gave results similar to those shown.  The percentage  of monocytes added  to the cultures, 
determined by nonspecific esterase staining was: 
Antimonocyte/  Anti-la/fresh 
Experiment  Control  fresh C'  C' 
1  30  0.5  6 
2  20  0.6  18 
3  15  0.7  10 VAN  VOORHIS ET  AL.  181 
ceinated 1  D9 was used to sort  1 D9  + (monocytes) from 1D9- cells on the FACS. 
In  establishing  the  gating  conditions  for  sorting,  we  noted  that  1D9  stained 
larger profiles in both adherent (Fig. 2A) and unfractionated mononuclear cells 
(not shown); also,  1 D9  staining was blocked by the addition of excess nonflu- 
oresceinated 3C 10 (Fig. 2 B) but not by 9.3F 10 (not shown). The success of the 
sorting  procedure  under  our  gating  condition  (Fig.  2C)  was  monitored  by 
cytology and  by  nonspecific  esterase  staining.  The  1D9 +  fraction  was  I>97% 
monocytes by both criteria, while the  1D9- fraction was 2% monocytes (Fig. 3, 
Table  IV).  The  1D9-  fraction  consisted  primarily  of lymphocytes,  but  also 
contained most of the dendritic cells. 
Adherent cells that had been sorted with fluoresceinated 1 D9 were tested for 
functional  activity.  Control  studies  indicated  that  exposure  to  1D9  did  not 
significantly alter the capacity of adherent cells to stimulate the MLR or oxidative 
mitogenesis (Table V, experiments 1,3), and that unsorted cells behaved similarly 
to mixtures of 1 D9  ÷ and 1D9- cells (Table V, experiment 1). When the accessory 
functions of the  sorted  populations  were  compared,  the  1D9-  or  monocyte- 
depleted fraction was consistently at least four times more active (Table V). Also, 
at least 75% of the total accessory activity was in the monocyte-depleted fraction, 
since the  1D9- cells represented  30-50%  of the total. The  1 D9  + or monocyte- 
enriched fraction weakly stimulated the allogeneic MLR and oxidative mitoge- 
nesis, and its stimulating capacity was comparable to that of nonadherent mono- 
nuclear cells. In most experiments, the syngeneic MLR was weak (<500  cpm), 
probably because dendritic cells were not greatly enriched by sorting; however, 
in one case (Table V, experiment 2), a  significant syngeneic MLR was induced 
only by the  monocyte-depleted populations.  We  conclude  that  monocytes are 
not the active accessory component of adherent cells from blood. 
Accessory Function of Highly  Enriched  Dendritic  Cells from  Blood.  To  obtain 
evidence  that  dendritic  cells  were  the  principal  accessory  cells  in  adherent 
populations, we used monoclonal antibodies (3C10, antimonocyte; BA-1, anti-B; 
and  Leu-1,  anti-T  cell)  to  prepare  highly enriched  dendritic  cells  that  were 
severely depleted of monocytes and lymphocytes (7, and Materials and Methods). 
Control  populations  were  exposed  to  C'  only and  therefore  contained  large 
numbers of monocytes, some  lymphocytes, and some (5-12%)  dendritic  cells. 
Fluorescence  T 
Zntensity 
) 
L~.eh ~ scatter 
FIGURE 2.  FAGS  profiles of adherent cells stained with fluoresceinated l D9 antimonocyte 
antibody. (A) The fluorescence vs. light scatter profile shows that 1  D9 stains most of the large 
cells. (B) A specificity  control in which the same cell populations were stained with fluorescein- 
ated 1  D9 in the presence of  a 20-fold  excess  of  nonfluoresceinated  3C 10, another antimonocyte 
antibody that competes with 1  D9 (7). (C) Gates used to sort 1  D9  + cells (upper rectangle) from 
t D9- cells (lower stripe); these gating conditions discarded cell aggregates and dead cells, but 
also 1,5% of viable single cells. 182  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
FIGURE 3.  Sorting of adherent blood mononuclear cells with fluoresceinated 1  D9 antimon- 
ocyte antibody. Most of the 1  D9  + cells (left) stain for nonspecific esterase. The  1D9- fraction 
(right) has  ~<2% monocytes  (arrows),  but  has  lymphoid  cells  with  single,  esterase-positive 
granules (arrowheads). x  160. 
TABLE  IV 
Cell Sorting of Mononuclear  Cells with Fluoresceinated  1D9 
Population sorted 
No.  Unfractionated  1D9  ÷ cells  ID9- cells 
of 
expts.  Fluor+  NSE+  Fluor+  NSE+  Fluor÷  NSE+ 
Peripheral  blood  mononuclear  1  21  22  97  95  0.5  0.5 
cells 
Adherent mononuclear cells  5  37  37  98  97  1  3 
+5  +6  -el  +2  +1  +-3 
Unfractionated mononuclear cells or plastic-adherent cells were stained with fluoresceinated  1D9 
and separated  into  ID9-positive and  1D9-negative fractions on the FACS  II,  or  left  unseparated 
(unfractionated). The three populations were then evaluated for the percent (mean ___ standard error) 
fluorescent cells (fluor  +) and percent cells staining diffusely for nonspecific esterase (NSE+). VAN  VOORHIS  ET  AL.  183 
TABLE  V 
Accessory Function of Adherent Blood Mononuclear Cells: Cell-sorting Studies with 
Fluoresceinated Antimonocyte Antibody 
Stimulator  Response (cpm [3H]thymidine) to graded doses of stimulators 
population  33%  16%  8%  33%  33%  16%  8% 
Oxidative mitogenesis  Syngeneic  Allogeneic MLR 
MLR 
Experiment 1 
Monocyte enriched  7,651  5,946  4,821 
( 1  D9  +) 
Monocyte depleted  50,216  31,281  16,884 
(ID9-) 
Unseparated,  36,598  23,042  15,769 
1  D9 treated 
Unseparated,  34,409  20,078  11,968 
not treated 
Sorted,  then  reconsti-  34,177  24,258  12,641 
tuted 
No stimulators  334 
Not tested  Not tested 
Experiment 2 
Monocyte enriched  17,675  13,517  12,685  140  32,329  25,993  14,052 
( 1  D9  +) 
Monocyte depleted  96,404  64,138  30,339  2,079  101,548  59,520  28,235 
(1D9-) 
Unseparated,  66,313  --  --  1,448  44,212  20,965  -- 
1  D9 treated 
Nonadherent cells  16,963  11,675  9,064  173  14,569  5,671  2,130 
Whole  blood  mononu-  38,648  23,450  13,316  303  36,609  27,929  14,612 
clear cells 
No stimulators  6,138  99  182 
Experiment 3 
Monocyte enriched  2,763  2,378  1,589  101  717  1,325  1,842 
(1 D9  +) 
Monocyte depleted  20,755  9,201  3,040  223  13,898  6,430  1,102 
(lO9-) 
Unseparated,  20,643  10,575  4,996  563  12,680  7,094  3,664 
1  D9 treated 
Unseparated,  26,433  13,776  6,217  515  17,442  10,033  6,730 
not treated 
Nonadherent cells  464  341  406  92  106  97  73 
Whole  blood  mononu-  17,954  7,063  2,955  94  8,813  3,200  312 
clear cells 
No stimulators  74  74  224 
The experiments were constructed as in Table I except that irradiated adherent mononuclear cells 
were used as accessory cells after cell sorting with fluoresceinated 1  D9 antimonocyte antibody. The 
percentage of fluorescent (fluor+)- and nonspecific esterase-positive (NSE  +) cells are tabulated below. 
In two of the experiments, the percentage of myeloperoxidase-positive cells was also measured and 
recorded in parentheses (after a day in culture, monocytes are not all peroxidase positive). 
1  D9  ÷  I D9-  Unseparated 
Experiment 
Fluor  +  NSE  +  Fluor  +  NSE  ÷  Fluor  +  NSE  ÷ 
1  97  97  1  1  22  25 
2  98  96 (69)  1  2  (2)  40  42 (36) 
3  99  98 (50)  1  0.6 (0.7)  35  38 (17) 184  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
The monocyte- and lymphocyte-depleted  adherent cells (primarily dendritic cells) 
were highly enriched in MLR-stimulating capacity, and were active at stimulator 
to responder ratios from 1:24 to 1:100 (Fig. 4). 
Purified dendritic cells were then compared to monocyte-enriched  populations 
as stimulators of the proliferative response to  soluble  tetanus toxoid antigen. 
Purified T  cells,  depleted of Ia  ÷ ceils with  9.3F10  and  C',  were used as  re- 
sponders. Accessory function in the dendritic cell fraction was clear-cut even at 
stimulator to responder ratios of 1:320 (Fig. 5). Monocyte-enriched populations 
were much less active (4-10-fold) and this activity may well have been due to 
contaminating dendritic cells. For example, 5-20% monocyte-enriched  cells were 
required to elicit significant tetanus toxoid responses (Fig. 5), yet previous studies 
had shown that monocytes could be depleted to a  level of 1%  with no loss of 
function (Table III). We conclude that dendritic cells, in the virtual absence of 
monocytes and lymphocytes, are potent stimulators of proliferative responses to 
soluble antigens. 
Contribution  of Class II (la-like) Molecules  to Accessory Function.  Treatment with 
the anti-class  II antibody 9.3F10  and  C'  eliminates accessory function (Table 
I-III) but does not affect T  cell responsiveness (Fig.  5). Class II molecules could 
either be a marker for active accessory cells such as dendritic cells (1-4), and/or 
could contribute directly to  function.  Evidence for the latter was obtained in 
experiments in which the Fab fragment of 9.3F10 was present continuously. T 
cell proliferation in the allogeneic MLR, the syngeneic MLR, oxidative mitoge- 
nesis, and the tetanus toxoid response was blocked by 9.3F10 Fab, in most cases 
by 80-90%  (Fig.  6).  No  inhibition  was  seen  with two  other monoclonal Fab 
fragments, the anti-Fc receptor reagent 3G8 (8) and the antimonocyte antibody 
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FIGURE 4.  Allogeneic MLR-stimulating capacity of enriched dendritic cells. Dendritic cells 
were enriched from adherent mononuclear cells by eliminating monocytes and lymphocytes 
with monoclonal antibodies and C' (see Materials and Methods). The viable cells, which were 
65-75% dendritic cells, were retrieved by flotation on dense albumin columns. Low density 
cells were also obtained from adherent populations exposed to  C'  only; these control cells 
were 60% monocytes, and 5-12% dendritic cells. In both experiments, stimulation by whole 
blood mononuclear cells is presented for comparison; however these cells were not exposed 
to Ab, C', or albumin columns. [SH]thymidine uptake of T  cells in the absence of stimulators 
was 151 and 224 cpm, respectively. VAN  VOORHIS  ET  AL. 
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FIGURE 5.  Stimulatory capacity of dendritic  cells in  the proliferative response  to  tetanus 
toxoid antigen and  in  the syngeneic MLR  (no antigen).  As in  Fig.  4,  adherent  cells were 
treated with cytolytic 3C10, BA-1, and Leu-1 antibodies to provide dendritic cells that were 
75% pure.  Control low density adherent  cells were exposed  to C' only and  were primarily 
monocytes. Monocytes were also obtained from firmly adherent cells (1); the latter contained 
small numbers of dendritic cells and were not exposed to antibodies, C', or albumin columns. 
Dotted lines show the uptake of [3H]thymidine in the absence of stimulator cells. 
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FIGURE 6.  Inhibition of T  cell proliferation with an Fab fragment of an anti-HLA class  II 
(anti-Ia) monoclonal antibody.  Four  T  cell proliferative responses  were carried  out  in  the 
presence of intact anti-la (9.3F10,  6  ug/ml),  Fab fragments (6 #g/ml) of 9.3F10,  and  two 
controls, antimonocyte 3C10 and anti-Fc7 receptor 3G8. 
3C10 (7). 
Purified monocytes and dendritic cells were then evaluated for reactivity with 
9.3F10 (Table VI). Most if not all monocytes and dendritic cells were stained by 
indirect immunofluorescence. In quantitative binding studies with  12~I-9.3F10 
Fab, monocytes and dendritic cells both expressed -~ 150,000 binding sites per 186  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
TABLE  VI 
Quantitation of HLA-class II Molecules on Monocytes and 
Dendritic Cells 
Cells  Percent  ng bound/  9.3F10  binding 
la  +  105 cells  sites/cell 
Experiment 1 
Dendritic cells  81  0.99  118,000 
Low density adherent  99  1.23  149,000 
cells 
Monocytes  97  1.28  159,000 
Experiment 2 
Dendritic cells  65  0.90  108,000 
Monocytes  95  1.06  131,000 
Dendritic cells (80 and 62% pure by cytologic criteria) were prepared by 
the antibody-mediated cytolysis method. Control or low density adherent 
cells were treated with C' only, and this population was 71% monocytes, 
12%  dendritic cells, and  17%  lymphocytes.  Highly enriched monocytes 
were obtained from the persistently adherent population and were >90% 
monocytes. The number of Ia  + cells in each population was determined 
by immunofluorescence with 9.3F10. Binding of 125I-9.3F10 Fab (specific 
activity of 6 X 106 cpm/~g) was determined in duplicate for two saturating 
concentrations  (2.5-10  ug/ml).  The  value shown  is  the  mean  of the 
determinations with a  standard  error of <15%.  Data are expressed per 
la  + cell. 
cell.  We conclude that class  II products are needed but must be expressed on 
dendritic cells to stimulate the T  cell proliferative responses studied in this paper. 
Discussion 
It is  well  known that accessory cells  from  human blood adhere to glass or 
plastic.  For example, stimulator cells  for the primary MLR and for oxidative 
mitogenesis are enriched in an adherent fraction that represents 20-30% of total 
mononuclear cells;  the nonadherent population, which contains most of the T 
cells and many of the B cells,  is weak or inactive (e.g., experiments 2, 3, Table 
V). The monocyte is the predominant adherent cell and is often assumed to be 
responsible  for accessory function.  Small  numbers  of dendritic  cells  also  are 
present in adherent populations (1,  2). If one is to determine how accessory cells 
initiate immune responses, it is essential to analyze the capacities of each adherent 
cell  type,  no  less  so  than  analyzing the  different kinds  of lymphocytes that 
mediate immunity. However, the characterization of dendritic cells  in man has 
been  more demanding than in mouse or rat.  Human blood has a  large (--~20- 
fold) excess of monocytes relative to dendritic cells.  Also, the two cell types do 
not differ as much in physical properties (buoyant density and capacity to adhere 
firmly to  glass  or plastic) as  do their rodent counterparts.  Therefore has  not 
been clear whether monocytes can function as accessory cells, or if the function 
of dendritic cell-enriched preparations has been due to dendritic cells alone. In 
this  paper,  we  have  used  monoctonal  antimonocyte and  anti-HLA  class  II 
antibodies to further characterize accessory cells in man. 
Selective  Depletion  of Monocytes.  The  first  approach  was  to  eliminate  most 
(>95%) of the monocytes with specific antibody and rabbit C' (Fig.  1,  Tables VAN  VOORH1S  ET  AL.  187 
I-III). This treatment did not kill  dendritic cells or other cell types (7).  Elimi- 
nation  of monocytes did  not  reduce stimulation  of the  MLR  and  oxidative 
mitogenesis, and did not reduce proliferative responses to the soluble antigens, 
Candida albicans and tetanus toxoid. It would be difficult to establish whether 
treatment with 3C10 and C' removed every monocyte, and often it is reasoned 
that one must remove virtually every macrophage to render lymphocytes acces- 
sory cell dependent.  However, this hypothesis is inconsistent with many dose- 
response studies in which it has been observed that much larger numbers (5-30% 
of the culture) of adherent cells are required to fully reconstitute lymphocyte 
function after depletion of adherent ceils (9-15). It is possible that small numbers 
of monocytes exert atrophic effect in vitro, but our data suggest that the key 
accessory cell that must be removed and replenished is the dendritic cell rather 
than the monocyte. 
Previous  studies  have  made relatively little  use  of specific antimacrophage 
antibodies and C'  to deplete accessory function. Raft et al.  (16) described the 
"Mac-120" monoclonal, which can kill  ,~50%  of monocytes and reduce stimu- 
lator  function  for  the  syngeneic  MLR  and  for antigen-induced proliferative 
responses.  It  has  not  been  established  if treatment  with  Mac-120  alters  the 
function of dendritic cells. This possibility must be entertained since 3C 10 killed 
>95% of monocytes but did not reduce accessory function even under limiting 
assay conditions (Tables I-III). 
Positive Selection of Monocytes.  The  second  approach  in  this  paper  was  to 
separate adherent mononuclear cells into monocyte-rich and -poor populations 
using fluoresceinated antimonocyte antibodies and the FACS (Figs.  2, 3, Tables 
IV, V).  Sorting provided, in one step and in good yield, populations that were 
997% and ~2% monocytes by esterase staining and by cytology. The monocyte- 
depleted fractions, which contained the dendritic cells, had the bulk (~75%) of 
the accessory activity. The monocyte-rich fraction exhibited only weak activity, 
comparable to that seen with nonadherent mononuclear cells. Rosenberg et al. 
(17)  noted that  monocytes, selected with the 63D3  antimonocyte monoclonal 
antibody, restored pokeweed mitogen responses in  sparse  cultures.  However, 
dose responses comparing monocytes and dendritic cells in this assay were not 
presented, and it was not clear whether both dendritic cells and/or monocytes 
had to be removed to render lymphocytes accessory cell dependent. The  1D9 
sorting experiment (Table V) represents the first time in which macrophages 
and  dendritic  cells  have  been  separated  from  one  another  using  a  specific 
antibody.  Analogous  experiments  have  been  performed  with  mouse  spleen 
adherent cells  using a  one  step  readherence method.  The  dendritic cell-rich 
component contained most of the stimulatory capacity for the MLR (3, 18), and 
for the development of hapten-specific cytolytic T  cells (19). 
In interpreting positive and negative selection experiments, one must consider 
the fact that monocytes can inhibit lymphocyte responses in vitro (e.g., 20-22). 
Typically, however, the addition of monocytes to dendritic cells (Table IV  in 
reference  1)  or  to  monocyte-depleted adherent  cells  (this  paper,  Table  V, 
experiment 1) does not reduce accessory function. In our experience, inhibition 
of T  cell  responses  has  been  apparent  only at  high  doses,  corresponding to 
30-50% monocytes. The experiments reported here were performed at relatively 188  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
low monocyte to T  cell ratios, where inhibition likely was insignificant. It is of 
interest that one can generate responses in monocyte-depleted cultures, so that 
it  should  now be  possible  to  obviate  monocyte suppression  whenever it  does 
Occur. 
Function of Purified, Monocyte-depIeted Dendritic Cells.  Antimonocyte antibodies 
were  used  in  a  third  type  of study  that  considered  the  capacity of purified 
dendritic  cells  to  stimulate  T  cells  in  the  primary  MLR  and  tetanus  toxoid 
response  (Figs.  4,  5).  In  our previous  work  (1),  dendritic cells were purified 
entirely by "physical" techniques. These cells lost the capacity to adhere to plastic 
after overnight culture (unlike most monocytes) and had a low buoyant density 
(unlike most lymphocytes). A dendritic cell-enriched fraction could be obtained 
by selecting adherent mononuclear cells that, after culture, were low density and 
loosely adherent. Yet these preparations contained at least 10%  monocytes and 
lymphocytes, which  could  have  contributed  to  function.  Contaminating  cells 
could be removed by rosetting methods (erythrocytes  treated with neuraminidase 
for T cells; with antibody for Fc receptor-bearing monocytes; or with anti-human 
Ig for B cells), but only with a  considerable loss of dendritic cells. In contrast, 
elimination  of monocytes and  lymphocytes with  specific  cytolytic antibodies 
(3C10, BA-1, Leu-1) provided dendritic cells that were highly enriched, in good 
yield, and depleted of contaminating cells by standard criteria. These enriched 
preparations of dendritic cells were strong stimulators of T  cell proliferation to 
alloantigens and soluble proteins (Figs.  4, 5). Activity was detected at stimulator 
to responder ratios of 1:100 or less. 
The identification of accessory cells could be made more rigorous if one could 
relate activity in any cell population with the precise content of dendritic cells. 
This is not yet possible for three reasons. First, low frequencies of dendritic cells 
(0.1-3.0%),  as occurs in  unfractionated blood and monocyte-enriched popula- 
tions,  cannot be enumerated rigorously. Second, the purification of dendritic 
cells, monocytes, and responding T  cells requires procedures that often cannot 
be applied uniformly to every population under study. Third, small numbers of 
dendritic cells in either the stimulator or responder populations  may enhance 
responses to other cells. Thus mouse spleen dendritic cells enhance cytolytic T 
cell responses to hapten and class I alloantigens on T  cells and on Ia- splenocytes 
(19,  23).  Given  the  strong  stimulatory  capacity of dendritic  cells,  the  weak 
capacity of monocytes and lymphocytes, and the failure to observe any loss of 
function with extensive monocyte and lymphocyte depletion (1,  2, this paper), 
we would conclude that the dendritic cell is the principal accessory cell in blood. 
Contribution of HLA-class  H Molecules to T Cell Growth.  An extensive literature 
documents the fact that class II products of the major histocompatibility complex 
act as restriction elements for T  cells. We have used a new monoclonal, 9.3F10, 
to  study  the  contribution  of HLA-class  II  molecules to  the  MLR,  oxidative 
mitogenesis, and the tetanus toxoid response. Although the determinant identi- 
fied by 9.3F10 is not known, the antibody precipitates a 33,000/29,000  tool wt 
doublet typical of class  II  products,  and  reacts  with  most monocytes, B  cells, 
dendritic cells, and Ia  + cell lines.  Conceivably, 9.3F10  recognizes a  specificity 
common to products of many class  II  loci, since it has the notable capacity to 
block T  cell  proliferation even when used as an  Fab  fragment (Fig.  6).  Our VAN  VOORHIS  ET  AL.  189 
working hypothesis is that 9.3F10  allows one to quantitate those Ia molecules 
needed for the proliferation of most class  II-restricted T  cells. Strikingly, both 
dendritic cells and monocytes bind comparable amounts of 9.3F10  Fab (Table 
VI). Since monocytes are weak or inactive in stimulating T  cell growth, it seems 
that class II products must be present on dendritic cells to initiate replication. 
Most likely, 9.3F 10 blocks replication by inhibiting the recognition of dendritic 
cell class  II products. Studies in mice and guinea pigs indicate that monoclonai 
anti-Ia antibodies can block function at the level of the accessory cell (e.g., 24, 
25).  It  has been reported that anti-Ia can also  inhibit the  T  cell response to 
interleukins (26).  However, interleukin-mediated human T  cell growth, moni- 
tored as described recently in a routine model (5),  was not inhibited by 9.3F10 
(J. M. Austyn, personal communication). 
It is not clear why Ia  + human monocytes and dendritic cells have such different 
functional capacities. Comparable observations have been made in studies of Ia  ÷ 
macrophages in mice (3-6,  18, 19, 27). We favor the idea that dendritic cells are 
differentiated to induce responses in  unprimed, resting or memory T  cells, as 
were studied in this paper.  The dendritic cell probably acts directly to initiate 
the response of class  II-restricted cells, as well as indirectly on other T  cells by 
controlling the release of soluble mediators like T  cell growth factor (5).  Ia  + 
monocytes may very well interact directly with class II-restricted activated T  cells 
or their products  during the effector limb of the  immune response.  Yet  the 
monocyte does not mediate the formation of sensitized cells, which appears to 
be the function of specialized dendritic cells. 
Summary 
Monocyte-specific monoclonal antibodies (7) were used to compare the efficacy 
of monocytes and dendritic cells as accessory or stimulator cells for human T 
cell replication. Both unfractionated and plastic-adherent mononuclear cells were 
first treated with a cytolytic antimonocyte antibody that kills >95% of monocytes 
but not dendritic cells. When tested as stimulators of  the mixed leukocyte reaction 
(MLR) and of oxidative mitogenesis (the proliferation of T  cells modified with 
sodium periodate), the monocyte-depleted cells had normal or enhanced stimu- 
latory capacity. Monocyte-depleted mononuclear cells also proliferated normally 
to  soluble  antigens  (Candida  aibicans,  tetanus  toxoid),  even  under  limiting 
conditions of cell dose, antigen dose, and culture time. Adherent blood mono- 
nuclear cells were next separated into monocyte-enriched and -depleted com- 
ponents using fluoresceinated antimonocyte antibody and the cell sorter.  The 
depleted fraction (<2% monocytes by esterase staining and by cytology)  contained 
the dendritic cells and  exhibited  at  least  75%  of the accessory activity.  The 
monocyte-rich fraction (~-97%  esterase positive) stimulated the MLR and oxi- 
dative mitogenesis weakly, and was comparable in potency to nonadherent cells. 
Cell-specific antibodies and complement were also used to prepare dendritic cells 
that  were thoroughly depleted of monocytes and  lymphocytes. The dendritic 
cells (70-80%  pure) were potent stimulators of the allogeneic MLR, syngeneic 
MLR, and tetanus toxoid response, being active at stimulator to responder ratios 
of 1:100 or less. Taken together with previous studies (1, 2), these experiments 
indicate that  the dendritic cell is the major stimulator of T  cell replication  in 190  ACCESSORY  FUNCTION  OF  HUMAN  MONOCYTES  AND  DENDRITIC  CELLS 
mail. 
The contribution of class II products of the major histocompatibility complex 
(7) was then evaluated with a  new monoclonal, 9.3F10.  Accessory function was 
dramatically inhibited if cells bearing class  II antigens  were killed with  9.3F10 
and complement, or if class II molecules were blocked by the addition of 9.3F10 
Fab  to  the  culture  medium.  The  expression  of 9.3F10  class  II  products  was 
therefore studied on purified monocytes and dendritic cells. Most if not all cells 
in  both  populations  reacted  with  9.3F10,  and  each  population  exhibited 
~-150,000  ~25I-Fab  9.3F10  binding  sites per  cell.  Since  Ia  + dendritic  cells are 
active accessory cells, but Ia  + monocytes are not, class II products are necessary 
but not sufficient for the stimulation of T  cell proliferation in man. 
Received for publication  16 March  1983. 
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